These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12195815)

  • 1. RNA-acting antibiotics: in-vitro selection of RNA aptamers for the design of new bioactive molecules less susceptible to bacterial resistance.
    Maurel MC; Biard B; Moulinier C; Braz D; Nugier J; Chaumas I; Reboud-Ravaux M; Décout JL
    J Pharm Pharmacol; 2002 Aug; 54(8):1019-31. PubMed ID: 12195815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.
    Shakil S; Khan R; Zarrilli R; Khan AU
    J Biomed Sci; 2008 Jan; 15(1):5-14. PubMed ID: 17657587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide antibiotic interaction and resistance on the bacterial ribosome.
    Poehlsgaard J; Douthwaite S
    Curr Opin Investig Drugs; 2003 Feb; 4(2):140-8. PubMed ID: 12669373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the use of conformationally locked aminoglycosides as a new strategy to overcome bacterial resistance.
    Bastida A; Hidalgo A; Chiara JL; Torrado M; Corzana F; Pérez-Cañadillas JM; Groves P; Garcia-Junceda E; Gonzalez C; Jimenez-Barbero J; Asensio JL
    J Am Chem Soc; 2006 Jan; 128(1):100-16. PubMed ID: 16390137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New strategies for combating multidrug-resistant bacteria.
    Wright GD; Sutherland AD
    Trends Mol Med; 2007 Jun; 13(6):260-7. PubMed ID: 17493872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface plasmon resonance evaluation of various aminoglycoside-RNA hairpin interactions reveals low degree of selectivity.
    Verhelst SH; Michiels PJ; van der Marel GA; van Boeckel CA; van Boom JH
    Chembiochem; 2004 Jul; 5(7):937-42. PubMed ID: 15239050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting genomics, genetics and chemistry to combat antibiotic resistance.
    Hughes D
    Nat Rev Genet; 2003 Jun; 4(6):432-41. PubMed ID: 12776213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design, synthesis and A-site rRNA co-crystal complexes of novel amphiphilic aminoglycoside antibiotics with new binding modes: a synergistic hydrophobic effect against resistant bacteria.
    Hanessian S; Pachamuthu K; Szychowski J; Giguère A; Swayze EE; Migawa MT; François B; Kondo J; Westhof E
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7097-101. PubMed ID: 20970332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications of aminoglycoside antibiotics targeting RNA.
    Zhou J; Wang G; Zhang LH; Ye XS
    Med Res Rev; 2007 May; 27(3):279-316. PubMed ID: 16892199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based drug design meets the ribosome.
    Franceschi F; Duffy EM
    Biochem Pharmacol; 2006 Mar; 71(7):1016-25. PubMed ID: 16443192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular recognition of aminoglycoside antibiotics by ribosomal RNA and resistance enzymes: an analysis of x-ray crystal structures.
    Vicens Q; Westhof E
    Biopolymers; 2003 Sep; 70(1):42-57. PubMed ID: 12925992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular contacts between antibiotics and the 30S ribosomal particle.
    Wirmer J; Westhof E
    Methods Enzymol; 2006; 415():180-202. PubMed ID: 17116475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamics of aminoglycoside-rRNA recognition.
    Pilch DS; Kaul M; Barbieri CM; Kerrigan JE
    Biopolymers; 2003 Sep; 70(1):58-79. PubMed ID: 12925993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacterial resistance and study of new antibiotics].
    Xiao CL; Yao TJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):351-3. PubMed ID: 15379254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view.
    Lynch AS
    Biochem Pharmacol; 2006 Mar; 71(7):949-56. PubMed ID: 16290174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving on nature: antibiotics that target the ribosome.
    Sutcliffe JA
    Curr Opin Microbiol; 2005 Oct; 8(5):534-42. PubMed ID: 16111914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiresistance?
    Nuotio L
    Med Hypotheses; 2009 Mar; 72(3):250-1. PubMed ID: 19010603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance: a survival strategy.
    Sheldon AT
    Clin Lab Sci; 2005; 18(3):170-80. PubMed ID: 16134477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular understanding of aminoglycoside action and resistance.
    Jana S; Deb JK
    Appl Microbiol Biotechnol; 2006 Mar; 70(2):140-50. PubMed ID: 16391922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.